Posted by Michael Wonder on 05 Aug 2024
FDA submission to expand minimum age for Xenoview
1 August 2024 - Polarean Imaging announces that it has submitted a new drug application supplement to the US FDA to allow the administration of Xenoview to paediatric patients aged six years and older.
This supplement includes updates to the HPX Polarisation Measurement Station and new Xenoview dose delivery bag sizes.
